DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan · Delayed Price · Currency is TWD 33.55
-0.35 (-1.03%)
Feb 11, 2026, 1:30 PM CST
DIVA Laboratories Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 83.92 | 93.66 | 73.62 | 49.66 | 21.86 | 17.42 |
Depreciation & Amortization | 9.51 | 10.08 | 8.3 | 8.36 | 11.57 | 15.62 |
Other Amortization | 0.9 | 0.87 | 0.77 | 1.73 | 2.14 | 3.42 |
Loss (Gain) From Sale of Assets | 0.02 | - | 0.07 | -0.93 | -2.85 | -0.01 |
Asset Writedown & Restructuring Costs | - | - | - | 6.56 | - | 3.07 |
Loss (Gain) From Sale of Investments | -2.09 | 22.12 | 9.03 | 48.18 | -2.34 | 29.57 |
Loss (Gain) on Equity Investments | -0.49 | -1.71 | 7.16 | 1.03 | -2.16 | -1.09 |
Provision & Write-off of Bad Debts | 5.79 | -8.87 | 6.62 | 0.53 | 1.47 | -0.56 |
Other Operating Activities | -14.31 | -0.99 | 19.27 | 19.37 | -2.86 | -11.17 |
Change in Accounts Receivable | -62.99 | -50.21 | 70.14 | -91.57 | -3.71 | 17.23 |
Change in Inventory | -38.79 | 45.78 | 89.18 | 28.01 | -103.46 | -71.42 |
Change in Accounts Payable | 14.85 | 9.62 | -24.09 | -18.72 | 57.47 | -5.43 |
Change in Unearned Revenue | 0.4 | -2.6 | 0.29 | 2.61 | 0.61 | 0 |
Change in Other Net Operating Assets | 40.99 | 7.16 | -12.28 | 12.76 | 9.17 | -13.29 |
Operating Cash Flow | 57.86 | 123.14 | 252.91 | 73.19 | -11.39 | -16.64 |
Operating Cash Flow Growth | -63.50% | -51.31% | 245.57% | - | - | - |
Capital Expenditures | -2.03 | -1.5 | -7.49 | -10.34 | -12.14 | -20.75 |
Sale of Property, Plant & Equipment | - | - | - | 5.41 | 11.95 | 0.12 |
Sale (Purchase) of Intangibles | -0.16 | -0.63 | -0.2 | -1.07 | -0.71 | -1.01 |
Investment in Securities | - | - | - | - | 3.9 | -42.45 |
Other Investing Activities | 6.06 | 5.99 | 4.48 | 0.96 | -0.39 | 58.79 |
Investing Cash Flow | 3.86 | 3.86 | -3.2 | -5.05 | 2.62 | -5.3 |
Short-Term Debt Issued | - | 50 | 240 | 175 | 95 | 47 |
Total Debt Issued | 100 | 50 | 240 | 175 | 95 | 47 |
Short-Term Debt Repaid | - | -50 | -240 | -175 | -95 | -47 |
Long-Term Debt Repaid | - | -2.53 | -0.13 | -0.13 | -0.13 | -0.13 |
Total Debt Repaid | -102.55 | -52.53 | -240.13 | -175.13 | -95.13 | -47.13 |
Net Debt Issued (Repaid) | -2.55 | -2.53 | -0.13 | -0.13 | -0.13 | -0.13 |
Repurchase of Common Stock | - | - | - | - | - | -160.54 |
Common Dividends Paid | -117.34 | -73.34 | -58.67 | -21.71 | -15.25 | - |
Other Financing Activities | -0.22 | -0.21 | -0.33 | -0.2 | -0.11 | -0.06 |
Financing Cash Flow | -120.11 | -76.07 | -59.13 | -22.04 | -15.49 | -160.72 |
Foreign Exchange Rate Adjustments | -1.09 | 1.3 | -0.02 | 0.99 | -0.22 | -0.24 |
Net Cash Flow | -59.48 | 52.22 | 190.56 | 47.09 | -24.48 | -182.9 |
Free Cash Flow | 55.82 | 121.63 | 245.43 | 62.84 | -23.53 | -37.4 |
Free Cash Flow Growth | -64.42% | -50.44% | 290.54% | - | - | - |
Free Cash Flow Margin | 6.47% | 14.11% | 27.46% | 6.62% | -3.30% | -5.08% |
Free Cash Flow Per Share | 0.95 | 2.06 | 4.17 | 1.07 | -0.40 | -0.56 |
Cash Interest Paid | 0.22 | 0.21 | 0.33 | 0.2 | 0.11 | 0.06 |
Cash Income Tax Paid | 14.33 | 17.03 | 22.51 | 3.52 | 10.04 | 14.34 |
Levered Free Cash Flow | 37.99 | 99.4 | 235.62 | 39.16 | -26.96 | -47.93 |
Unlevered Free Cash Flow | 38.13 | 99.53 | 235.83 | 39.29 | -26.89 | -47.9 |
Change in Working Capital | -25.39 | 7.98 | 128.1 | -61.3 | -38.22 | -72.91 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.